Thomas J. Riga - Jan 3, 2023 Form 4 Insider Report for SPECTRUM PHARMACEUTICALS INC (SPPI)

Role
CEO & President, Director
Signature
/s/ Keith M. McGahan, Attorney-in-Fact for Thomas J. Riga
Stock symbol
SPPI
Transactions as of
Jan 3, 2023
Transactions value $
-$9,141
Form type
4
Date filed
1/5/2023, 06:50 PM
Previous filing
Feb 13, 2023
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPPI Common Stock, $0.001 par value Sale -$9.14K -23.9K -1.97% $0.38 1.19M Jan 3, 2023 Direct F1
transaction SPPI Common Stock, $0.001 par value Award $0 +888K +74.66% $0.00 2.08M Jan 3, 2023 Direct F2
holding SPPI Common Stock, $0.001 par value 14.1K Jan 3, 2023 By 401(k) plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPPI Stock Option (Right to Buy) Award $0 +3.11M $0.00 3.11M Jan 3, 2023 Common Stock 3.11M $0.38 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
F2 One third of the aggregate amount of restricted stock units shall vest on each of January 3, 2024, 2025 and 2026, respectively.
F3 One third of the aggregate amount of option shares shall vest on each of January 3, 2024, 2025 and 2026, respectively.